TY - JOUR
T1 - The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis
AU - Machold, Klaus P.
AU - Landewe, Robert
AU - Smolen, Josef S.
AU - Stamm, Tanja A.
AU - van der Heijde, Desiree M.
AU - Verpoort, Kirsten N.
AU - Brickmann, Kerstin
AU - Vazquez-Mellado, Janitzia
AU - Karateev, Dimitri E.
AU - Breedveld, Ferdinand C.
AU - Emery, Paul
AU - Huizinga, Thomas W. J.
PY - 2010/3
Y1 - 2010/3
N2 - Background Glucocorticoids (GCs) are often used as early arthritis treatment and it has been suggested that they induce remission or at least delay the development of rheumatoid arthritis (RA) and the need to start disease-modifying antirheumatic drugs (DMARDs). Objective To test the effect of GCs on patients with very early arthritis (symptom duration of
AB - Background Glucocorticoids (GCs) are often used as early arthritis treatment and it has been suggested that they induce remission or at least delay the development of rheumatoid arthritis (RA) and the need to start disease-modifying antirheumatic drugs (DMARDs). Objective To test the effect of GCs on patients with very early arthritis (symptom duration of
U2 - 10.1136/ard.2009.122473
DO - 10.1136/ard.2009.122473
M3 - Article
C2 - 20223838
SN - 0003-4967
VL - 69
SP - 495
EP - 502
JO - Annals of the Rheumatic Diseases
JF - Annals of the Rheumatic Diseases
IS - 3
ER -